Applications for the Pulmonary Hypertension/Pulmonary Vascular Disease (PH/PVD) Fellowship at the University of Pennsylvania for the academic year starting July 2025 are open.

Cereno Scientific, a pioneering biotech developing innovative treatments for rare and common cardiovascular diseases, has joined PVRI as a Roundtable member.

The Burke Advanced Fellowship in Pulmonary Heart Disease at The Brigham and Women’s Hospital and Harvard Medical School invites applications for an advanced fellowship in pulmonary heart disease starting 1 July 2025.

Rupert Swift, a brave, bold, clever, charismatic young man who embraced life to the full, developed high altitude pulmonary oedema and 3 months later, was diagnosed with functional class 3 pulmonary hypertension. 

Last year Sam, Max, and Harri completed the London Tough Mudder to raise money for the PVRI. After raising an incredible £3,742 which put them in the top three Tough Mudder fundraisers of 2023, they are back this year to compete again joined by Toby and Harrison. 

The PVRI joins the community of physicians, scientists, patients and their families in mourning Dr John Newman’s passing on the 20 February 2024. 

Our new logo, launched at the PVRI 2024 Congress in London, 31 January – 4 February, captured the hearts and minds of over 500 pulmonary hypertension experts, researchers, industry, charity partners, drug regulators, and patients from over 31 countries.

Applications are invited for a British Heart Foundation-funded position of Post-Doctoral Research Associate to investigate the complex process of systemic metabolic adaptation during the initiation and development of pulmonary hypertension (PH). 

Following a successful Presidency in the hands of Dr Kurt Stenmark, we are very proud to welcome Dr Anna Hemnes as our new President from the 3 February 2024.